The effect of specific binding proteins on immunoassay measurements of total and free thyroid hormones and cortisol.
Publication Title
Ther Adv Endocrinol Metab
Document Type
Article
Publication Date
1-1-2021
Keywords
california; santa monica; jwci; pacific neurosciences
Abstract
Background: Immunoassay (IA) measurements of thyroid hormones have previously given inaccurate results of triiodothyronine (T3), free triiodothyronine (FT3), and free thyroxine (FT4) when concentrations of TBG are low. We evaluate the hypothesis that abnormal concentrations of specific binding proteins (BPs) affect IA measurements and provide results which might misguide the diagnosis and treatment of patients. This study assesses IAs for the measurement of T3, FT3, and cortisol when levels of TBG and CBG are high or low. Comparisons are made between IA and LC-MS/MS.
Methods: Serum or plasma samples with high (>95th percentile,
Results: When TBG levels are <5th >percentile, the differences between the IA and LC-MS/MS results for T3 and FT3 are statistically significant (T3,
Conclusion: Abnormal BP concentrations appear to affect the accuracy of IA measurements of T3, FT3, and cortisol. The population of patients with either high or low levels of BPs is significant. Our samples reflect that 65% of women aged between 15 and 49 years are taking oral contraceptives in the US, and thus have elevated levels of BPs. In this group, IA results for cortisol are falsely low. Our samples reflect that patients with protein losing diseases have low BP concentrations. Among a group with renal complications, IA measurements of T3 are overestimated, while those of FT3 are underestimated. Are the Food and Drug Administration and diagnostic companies adequately assessing the accuracy of IA tests?
Clinical Institute
Neurosciences (Brain & Spine)
Specialty/Research Institute
Endocrinology
